CAMP4 THERAPEUTICS CORPORATION (CAMP NASDAQ) stock market data APIs
$1.9926
-0.39(-19.6%)
as of April 17, 2025
CAMP4 THERAPEUTICS CORPORATION Financial Data Overview
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Prev. Close
1.9926
Open
1.6053
High
2.0329
Low
1.6053
52 wk Range
1.61-12.3
Market Cap
103 M
Shares Outstanding
20 161 K
EPS
-0.6592
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CAMP4 THERAPEUTICS CORPORATION data using free add-ons & libraries
Get CAMP4 THERAPEUTICS CORPORATION Fundamental Data
CAMP4 THERAPEUTICS CORPORATION Fundamental data includes:
- Net Revenue:
- EBITDA: -50 817 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CAMP4 THERAPEUTICS CORPORATION News
New
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
– Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four multiple ascending dose (MAD) cohorts; safety, pharmacokinetic, and pharmacodynam...
CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025
IRVINE, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- CalAmp (Nasdaq: CAMP), a global technology leader in telematics and fleet intelligence, is excited to announce its participation in the STN East C...
CAMP4 to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting anti...
CalAmp Corp. (NASDAQ:CAMP) Q3 2024 Earnings Call Transcript
CalAmp Corp. (NASDAQ:CAMP) Q3 2024 Earnings Call Transcript January 9, 2024 CalAmp Corp. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.1. CAMP isn't one of the 30...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
